Samumed Revenue and Competitors
Estimated Revenue & Valuation
- Samumed's estimated annual revenue is currently $36.4M per year.
- Samumed received $440.0M in venture funding in November 2018. 0
- Samumed's total funding is $778M.
- Samumed's current valuation is $12B.
Samumed Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Samumed?
Samumed is a leader in medical research and development for tissue-level regeneration. With our platform's origins in small molecule-based Wnt pathway modulation, we develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.keywords:Biotechnology,Customer Support,Education,Healthcare,Human Resources Hr,Pharmaceuticals
Number of Employees
Employee Growth %
Osman Kibar, founder and CEO of biotech firm Samumed, with $2.3 billion. 1397. Phillip Frost, a long-time health care investor and founder,...
Founded in 2008, Samumed has spent most of its lifetime working under the radar. It came out of the shadows in 2016 with a war chest of $220 ...
Founded in 2008, Samumed has spent most of its lifetime working under the radar. It came out of the shadows in 2016 with a war chest of $220 million drawn from investors including Ikea’s private venture arm and some very wealthy individuals along with a pipeline of drugs it says can reverse agin ...
SAN DIEGO, May 02, 2019 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has finalized the design of its phase 3 clinical ...
SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has successfully completed an End-of-Phase 2 ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|2018-11-27||$440.0M||A||Vickers Venture Partners||Article|